COVID-19 was first identified in Wuhan, China in December 2019. The disease spread quickly and was declared as a global pandemic in March 2020 by the WHO (World Health Organization) Since then, no country has managed to avoid infection from the coronavirus.
In this blog post we bring together resources that are focused on how the COVID-19 pandemic has been affecting people who use drugs. We will also look at the impact on those that provide services to drug takers.
What is clear is that COVID-19 has had an affect on the drug market. This post compiles a range of articles and reports on resources on COVID-19 and drugs. Sources include the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and their partner organisations and others.
EMCDDA Publications
- Illicit drug markets and supply in the Western Balkans: Impact of COVID-19 – June 2021
- European Drug Report 2021: Trends and Developments – June 2021
- Exploring drug supply, associated violence and exploitation of vulnerable groups in Denmark – May 2021
- Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons – April 2021
- EMCDDA trendspotter briefing: Impact of COVID-19 on drug use and drug services in Western Balkans – March 2021
- Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in south ENP countries – December 2020
- New psychoactive substances: global markets, global threats and the COVID-19 pandemic – December 2020
- European Drug Report 2020: Key Issues – September 2020
Photo by Luke Jones on Unsplash
Zoom Testing is a leading UK drug testing company and a supplier of Drug Test Kits.
This post was originally published in October 2021.
